These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 9374377)
21. Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro. Latz D; Fleckenstein K; Eble M; Blatter J; Wannenmacher M; Weber KJ Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):875-82. PubMed ID: 9652852 [TBL] [Abstract][Full Text] [Related]
22. Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells. van Bree C; Rodermond H; Leen R; Medema J; van Kuilenburg A Br J Cancer; 2008 Apr; 98(7):1226-33. PubMed ID: 18349845 [TBL] [Abstract][Full Text] [Related]
23. Drug metabolism and homologous recombination repair in radiosensitization with gemcitabine. Im MM; Flanagan SA; Ackroyd JJ; Shewach DS Radiat Res; 2015 Jan; 183(1):114-23. PubMed ID: 25564718 [TBL] [Abstract][Full Text] [Related]
24. Genotoxicity kinetics in murine normoblasts as an approach for the in vivo action of difluorodeoxycytidine. Morales-Ramírez P; Vallarino-Kelly T; Cruz-Vallejo V Cancer Chemother Pharmacol; 2017 May; 79(5):843-853. PubMed ID: 28324147 [TBL] [Abstract][Full Text] [Related]
25. Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro. Pauwels B; Korst AE; Pattyn GG; Lambrechts HA; Van Bockstaele DR; Vermeulen K; Lenjou M; de Pooter CM; Vermorken JB; Lardon F Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1075-83. PubMed ID: 14575839 [TBL] [Abstract][Full Text] [Related]
26. Radiation enhancement of gemcitabine in two human squamous cell carcinoma cell lines. Mose S; Karapetian M; Jüling-Pohlit L; Taborski B; Damrau M; Ramm U; Rahn A; Böttcher HD Anticancer Res; 2000; 20(1A):401-5. PubMed ID: 10769687 [TBL] [Abstract][Full Text] [Related]
27. Regulation of phosphorylation of deoxycytidine and 2',2'-difluorodeoxycytidine (gemcitabine); effects of cytidine 5'-triphosphate and uridine 5'-triphosphate in relation to chemosensitivity for 2',2'-difluorodeoxycytidine. van Haperen VW; Veerman G; Vermorken JB; Pinedo HM; Peters G Biochem Pharmacol; 1996 Apr; 51(7):911-8. PubMed ID: 8651941 [TBL] [Abstract][Full Text] [Related]
28. Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumours. van Moorsel CJ; Pinedo HM; Smid K; Comijn EM; Voorn DA; Veerman G; Lakerveld B; Van der Vijgh WJ; Giaccone G; Postmus PE; Peters GJ Eur J Cancer; 2000 Dec; 36(18):2420-9. PubMed ID: 11094319 [TBL] [Abstract][Full Text] [Related]
29. WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment. Phan TP; Crane CH; Janjan NA; Vrdoljak E; Milas L; Mason KA Int J Pancreatol; 2001; 29(1):19-23. PubMed ID: 11558629 [TBL] [Abstract][Full Text] [Related]
30. Gemcitabine radiosensitizes multiple myeloma cells to low let, but not high let, irradiation. Supiot S; Thillays F; Rio E; Gouard S; Morgenstern A; Bruchertseifer F; Mahé MA; Chatal JF; Davodeau F; Chérel M Radiother Oncol; 2007 Apr; 83(1):97-101. PubMed ID: 17383762 [TBL] [Abstract][Full Text] [Related]
31. Effects of gemcitabine on cell survival and chromosome aberrations after pulsed low dose-rate irradiation. Castro Kreder N; Van Bree C; Franken NA; Haveman J J Radiat Res; 2004 Mar; 45(1):111-8. PubMed ID: 15133298 [TBL] [Abstract][Full Text] [Related]
32. Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine). Fields MT; Eisbruch A; Normolle D; Orfali A; Davis MA; Pu AT; Lawrence TS Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):785-91. PubMed ID: 10837965 [TBL] [Abstract][Full Text] [Related]
33. Late DNA Damage Mediated by Homologous Recombination Repair Results in Radiosensitization with Gemcitabine. Im MM; Flanagan SA; Ackroyd JJ; Knapp B; Kramer A; Shewach DS Radiat Res; 2016 Nov; 186(5):466-477. PubMed ID: 27740890 [TBL] [Abstract][Full Text] [Related]
34. The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines. Pauwels B; Korst AE; Pattyn GG; Lambrechts HA; Kamphuis JA; De Pooter CM; Peters GJ; Lardon F; Vermorken JB BMC Cancer; 2006 May; 6():142. PubMed ID: 16734894 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine. Heinemann V; Hertel LW; Grindey GB; Plunkett W Cancer Res; 1988 Jul; 48(14):4024-31. PubMed ID: 3383195 [TBL] [Abstract][Full Text] [Related]
37. Radiosensitization of human tumor cells by gemcitabine in vitro. Shewach DS; Lawrence TS Semin Oncol; 1995 Aug; 22(4 Suppl 11):68-71. PubMed ID: 7481848 [TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo study of a nanoliposomal cisplatin as a radiosensitizer. Zhang X; Yang H; Gu K; Chen J; Rui M; Jiang GL Int J Nanomedicine; 2011; 6():437-44. PubMed ID: 21499433 [TBL] [Abstract][Full Text] [Related]
39. Gemcitabine and radiosensitization in human tumor cells. Shewach DS; Lawrence TS Invest New Drugs; 1996; 14(3):257-63. PubMed ID: 8958180 [TBL] [Abstract][Full Text] [Related]
40. Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene. Beauséjour CM; Gagnon J; Primeau M; Momparler RL Biochem Biophys Res Commun; 2002 May; 293(5):1478-84. PubMed ID: 12054682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]